Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Infection and Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S10156-006-0497-0PMID 17458673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

  2007cited by this paper
• Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci.

  2006cited by this paper
• Antimicrobial Agent of Susceptibilities and Antiseptic Resistance Gene Distribution among Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Impetigo and Staphylococcal Scalded Skin Syndrome

  2006cited by this paper
• Trends of Arbekacin-resistant MRSA Strains in Japanese Hospitals (1979 to 2000)

  2006cited by this paper
• Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).

  2006cited by this paper
• In Vitro Activities of 28 Antimicrobial Agents against Staphylococcus aureus Isolates from Tertiary-Care Hospitals in Korea: a Nationwide Survey

  2004cited by this paper
• Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.

  2004cited by this paper
• Vancomycin-resistant Staphylococcus aureus--New York, 2004.

  2004cited by this paper
• Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

  2003cited by this paper
• [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penisillin-resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district].

  2003cited by this paper
• Copyright � The Korean Academy of Medical Sciences Multiplex PCR for the Detection of Genes Encoding Aminoglycoside Modifying Enzymes and Methicillin Resistance among Staphylococcus Species

  2003cited by this paper
• Molecular mechanism for the enhancement of arbekacin resistance in a methicillin‐resistant Staphylococcus aureus

  2003cited by this paper
• [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].

  2003cited by this paper
• Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site.

  2002cited by this paper
• Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.

  2002cited by this paper
• From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002.

  2002cited by this paper
• Staphylococcus aureus resistant to vancomycin--United States, 2002.

  2002cited by this paper
• Identification of Aminoglycoside-Modifying Enzymes by Susceptibility Testing: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Japan

  2001cited by this paper
• [Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci].

  2000cited by this paper
• Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance

  2000cited by this paper
• [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].

  1999cited by this paper
• Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications

  1999cited by this paper
• The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

  1999cited by this paper
• Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

  1997cited by this paper
• Clinical breakpoints for antimicrobial agents in pulmonary infections and sepsis: Report of The Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria

  1995cited by this paper
• Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. Belgian Study Group of Hospital Infections (GDEPIH/GOSPIZ).

  1994cited by this paper
• Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

  1992cited by this paper
• Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis

  1984cited by this paper
• Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic

  1983cited by this paper
• Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility

  year unknowncited by this paper

• Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches - an overview.

  2021cites this paper
• Diagnosis and Management of Infective Endocarditis

  2014cites this paper
• Arbekacin Tested against Well Characterized Multidrug-Resistant (MDR) Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus (MRSA)

  2014cites this paper
• Antibiotic Resistance in Clinical Methicillin- resistant Staphylococcus aureus Isolates of Three Different Hospitals in Ankara

  2013cites this paper
• Emergence of Staphylococcus aureus Carrying Multiple Drug Resistance Genes on a Plasmid Encoding Exfoliative Toxin B

  2013cites this paper
• Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility

  2012cites this paper
• Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens’ antibacterial susceptibility

  2011cites this paper
• Molecular Mechanisms of Antibiotic Resistance in Bacteria

  2010cites this paper
• Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility

  2009cites this paper
• TESTING THE SENSITIVITY OF Staphylococcus aureus ANTIBIOTICS

  2009cites this paper
• Structural Basis of APH(3′)-IIIa-Mediated Resistance to N1-Substituted Aminoglycoside Antibiotics

  2009cites this paper
• The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility

  2008cites this paper
• Trends of β-lactam antibiotic susceptibility in blood-borne methicillin-resistant Staphylococcus aureus (MRSA) and their linkage to the staphylococcal cassette chromosome mec (SCCmec) type

  2007cites this paper
• International Journal of General Medicine Dovepress a 25-year Trace of Methicillin-resistant Staphylococcus Aureus Dissemination in a Geriatric Hospital in Japan

  year unknowncites this paper